glp-1 receptor agonist type 1 diabetes randomized trial

glp-1 receptor agonist type 1 diabetes randomized trial SGLT2i and RA therapy in and reno-vascular outcomes: a real-world study | Diabetologia New Developments in Pharmacological Treatment

Name: glp-1 receptor agonist type 1 diabetes randomized trial SGLT2i and RA therapy in and reno-vascular outcomes: a real-world study | Diabetologia New Developments in Pharmacological Treatment
Brand: ctstranslates.com
SKU: 90245864084
Price: 23.69 USD
Availability: InStock
Rating: 4.0918 (27 reviews)

SKU: 90245864084

4.1

USD23.69 USD69.69

Pay in 4 interest-free payments of $5.92 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Description

Wall, B et al

This raises the possibility of GLP-1/GIP/glucagon receptor triagonist becoming a new treatment for the reversal of liver fibrosis in MASH

It was not possible to match HbA 1c to a mean value between cohorts

Diabetes Obes Metab 13(2):144149 Matza LS, Boye KS, Stewart KD et al (2020) Assessing patient PREFERence between the dulaglutide pen and the semaglutide pen: a crossover study (PREFER)